Summary & Overview
HCPCS A4555: Electrode/Transducer for Electrical Stimulation, Replacement Only
HCPCS Level II code A4555 identifies a replacement electrode/transducer for use with electrical stimulation devices applied in cancer treatment contexts. Nationally, the code matters because it defines billing for a specialized durable medical equipment (DME) component used in symptom control, neuropathic pain management, or adjunctive cancer therapies where electrical stimulation is employed. Clear coding supports appropriate coverage decisions and claims processing for replacement parts separate from initial device provision.
Key payers relevant to coverage and reimbursement policies include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will gain a concise overview of what A4555 represents, how it is categorized as a DME replacement item, and where it is typically used. The publication outlines national benchmarks and payer coverage patterns where available, highlights relevant policy updates affecting DME and replacement components, and provides clinical context about the role of electrical stimulation electrodes in cancer care. Where specific payer or clinical data are absent, the text notes that information is not available in the input. This summary is intended to orient billing staff, DME suppliers, and policy analysts to the code’s purpose and the scope of the accompanying analysis.
Billing Code Overview
HCPCS Level II code A4555 describes an electrode/transducer for use with an electrical stimulation device used for cancer treatment, replacement only. The service type is durable medical supply – replacement component for an electrical stimulation therapy system. The typical site of service is outpatient or clinic settings where electrical stimulation devices are used as part of cancer symptom management or palliative therapy, and may also include durable medical equipment suppliers for replacement parts.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult oncology patient receiving adjunctive electrical stimulation therapy for tumor pain control or to enhance local anti-cancer effects. The oncology clinic schedules an outpatient device session where a certified radiation therapist or oncology nurse applies disposable or reusable electrode/transducer pads to the patient’s skin over the treatment field. The device delivers therapeutic electrical stimulation per the prescribing oncologist’s protocol. The billed item A4555 represents a replacement electrode/transducer provided when the original accessory is depleted, damaged, or single‑patient use. Documentation includes the prescription or device order, product serial or lot number if applicable, device settings, site of placement, reason for replacement (routine replacement, damage, or loss), and the supervising clinician’s notes. Typical sites of service are outpatient oncology clinic, hospital outpatient department, or ambulatory procedure center. The patient scenario may involve ongoing multimodality cancer care (chemotherapy, radiation) with electrical stimulation used for symptomatic management or as part of an investigational protocol; replacement parts are supplied intermittently during the course of therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
NU | New equipment | Use when the electrode/transducer is the initial supply provided as new, if applicable per payer rules. |